The landscape of HER2-positive metastatic breast cancer treatment has undergone a significant transformation with the recent U.S....
Patient Advocacy and Support
The transition from active cancer treatment to survivorship is often described by patients as one of the...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-Like Peptide-1 (GLP-1)...
The campaign arrives at a critical juncture in oncology. While advancements in screening have improved survival rates...
The landscape of oncology is undergoing a transformative shift as the U.S. Food and Drug Administration (FDA)...
TORONTO, ON — As the medical community continues to make strides in early detection and acute treatment...
By Douglas Feil, NBCF Chief Program Officer The landscape of chronic disease management has been significantly reshaped...
NEW YORK, NY — As the world dons pink ribbons for Breast Cancer Awareness Month this October,...
The landscape of metastatic breast cancer (MBC) treatment has undergone a significant transformation with the recent U.S....
TORONTO, ON — As the medical community continues to make strides in the early detection and treatment...
